Literature DB >> 7608876

Vaginal columnar cell metaplasia. An acquired adenosis associated with topical 5-fluorouracil therapy.

C F Dungar1, E J Wilkinson.   

Abstract

Vaginal adenosis, with columnar epithelium of endocervical or endometrial type forming glands within the vagina, has been observed as a congenitally acquired process, associated with in utero exposure to diethylstilbestrol; approximately 20% of those women exposed in utero have adenosis. It has been observed that vaginal adenosis may occur in nonexposed women; the origin is thought to be acquired following puberty. This study analyzed eight patients who, following topical vaginal therapy with 5-fluorouracil for vaginal intraepithelial neoplasia, had unresolving, reddened areas in the upper one-third of the vagina. Biopsy of these areas demonstrated columnar epithelium on the vaginal surface, where stratified squamous epithelium would be expected. Superficial vaginal glands (adenosis) lined with epithelium identical to the surface columnar epithelium were also identified. This finding is consistent with a metaplastic process in which stratified squamous epithelium is replaced by columnar representing columnar cell metaplasia, or acquired vaginal adenosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608876

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Prevention of vulvovaginal sequelae in stevens-johnson syndrome and toxic epidermal necrolysis.

Authors:  Daniel J Kaser; David E Reichman; Marc R Laufer
Journal:  Rev Obstet Gynecol       Date:  2011

2.  Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy.

Authors:  Tamera A Paczos; Stacey Ackers; Kunle Odunsi; Shashikant Lele; Paulette Mhawech-Fauceglia
Journal:  Int J Gynecol Pathol       Date:  2010-03       Impact factor: 2.762

3.  A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.

Authors:  M M Holmes; S H Weaver; S T Vermillion
Journal:  Infect Dis Obstet Gynecol       Date:  1999

4.  SIX1 cooperates with RUNX1 and SMAD4 in cell fate commitment of Müllerian duct epithelium.

Authors:  Jumpei Terakawa; Vanida A Serna; Devi M Nair; Shigeru Sato; Kiyoshi Kawakami; Sally Radovick; Pascal Maire; Takeshi Kurita
Journal:  Cell Death Differ       Date:  2020-06-22       Impact factor: 15.828

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.